# Patrick Schöffski

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/patrick-schoffski/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,703 |
| Field | Gastrointestinal Tumor Research and Treatment |
| h-index | 93 |
| i10-index | 375 |
| Last Known Institution | Heidelberg University |
| OpenAlex ID | https://openalex.org/A5021550191 |
| ORCID iD | https://orcid.org/0000-0001-5980-030X |
| Works | 1,158 |

## Researcher papers

- [Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-for/)
- [Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-genturis-clinical-practice/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-for-diagnosis/)
- [Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial](https://scholariq.org/papers/safety-and-efficacy-of-sunitinib-for-metastatic-renal-cell-carcinoma-an-expanded/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-genturis-clinical-practice/)
- [Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience](https://scholariq.org/papers/neoadjuvant-imatinib-in-locally-advanced-gastrointestinal-stromal-tumors-gist/)
- [Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”](https://scholariq.org/papers/corrections-to-soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice/)
- [Corrections to “Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”](https://scholariq.org/papers/corrections-to-gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice/)

## Researcher topics

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Gastrointestinal disorders and treatments](https://scholariq.org/topics/gastrointestinal-disorders-and-treatments/)

## Researcher university

- [Heidelberg University](https://scholariq.org/institutions/heidelberg-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.